Bavarian Nordic secures USD97m US vaccine contract expansion and raises 2026 outlook

Cellular Intelligence and Novo Nordisk enter agreement to advance clinical-stage Parkinson's cell therapy

Ranok Therapeutics reports positive Phase 1a clinical results for KRAS G12D inhibitor RNK08954

Avid Bioservices names new chief commercial officer

AnaCardio reports Phase 1b/2a data showing cardiac function gains with AC01

Inhibrx reports positive interim Phase 2 data for INBRX-106 in first-line head and neck cancer

Anixa Biosciences reports extended survival signals in Phase 1 ovarian cancer CAR-T trial

Oncopeptides plans EMA filing to broaden Pepaxti indication

GSK partners with SBP Group to accelerate China launch of bepirovirsen

Harbour BioMed's HBM7004 receives US FDA IND clearance for Phase I trial

Wenda Pharma's oral BET inhibitor NHWD-870 HCI receives Breakthrough Therapy Designation in China in advanced NUT carcinoma

PureHealth Research introduces Berberine-infused natural GLP-1 supplements

Innovent's IBI363 receives third Chinese regulatory BTD for MSS/pMMR CRC

MHRA approves Efmody for adrenal insufficiency treatment

European Commission approves Bristol Myers Squibb's Sotyktu for psoriatic arthritis